Matches 1 - 50 out of 160 1 2 3 4 >


Match Document Document Title
US20120277180 Cofactors and Methods for Use for Individuals  
Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of...
US20140349979 STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME  
A stabilized formulation for controlled release of a vitamin D compound is disclosed. The formulation comprises one or both of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 and a cellulosic...
US20120015913 Formulations of 14-EPI-Analogues of Vitamin D  
The present invention provides new formulations of 14-epi-analogues of vitamin D, such as inecalcitol, providing improved absorption profile.
US20150141385 Methods Useful for Vitamin D Deficiency and Related Disorders  
Methods for diagnosing, treating, and preventing catabolism-related vitamin D deficiency and related disorders, related compositions, apparatus and kits, are disclosed. A method involves measuring...
US20150079165 Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3  
Methods and compositions for treating 25-hydroxyvitamin D insufficiency and deficiency in a patient are described herein. The method includes orally administering to the patient a delayed,...
US20120083614 (20R,25S)-2-Methylene-19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 in Crystalline Form  
A method of purifying (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 to obtain (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 in crystalline form. The method includes the...
US20130039952 CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS  
Calcipotriol monohydrate nanocrystals prepared by the process disclosed herein may be incorporated in a pharmaceutical composition for use in the prevention or treatment of dermal diseases and...
US20060135491 Vitamin D3 analog useful for the treatment of osteoporosis  
The present invention relates to the vitamin D3 analog (1R,3R)-5-{(E)-(2R, 5R)-2-[2-(4-hydroxy-4-methylpentyl)-spiro[4.5]dec-7-ylidene] -ethylidene}-cyclohexane-1,3-diol which is useful in the...
US20140248707 RELEASE REAGENT FOR VITAMIN D COMPOUNDS  
A reagent composition for releasing vitamin D compounds bound to vitamin D-binding protein and an in vitro method for the detection of a vitamin D compound in which the vitamin D compound is...
US20140154700 Compositions and Methods for Detecting Vitamin D  
Compounds include carbamate derivatives of vitamin D including vitamin D3 and vitamin D2. The compounds are useful in methods and kits for determining the presence and/or amount of vitamin D...
US20110059926 Vitamin D Compounds and Methods for Reducing Ocular Hypertension (OHT)  
The present invention relates to compounds and methods for reducing intraocular pressure and treating ocular hypertension in a subject.
US20130295083 2a-Methyl-19-nor-(20S)-1a,25-dihydroxyvitamin D3 (2AMD) or 2 methylene-19-nor-(20S)-1a,25-dihydroxyvitamin D3 (2MD) Support Survival and Function of Transplanted Islet Cells In Type 1 Diabetes  
A method of treating islet cell transplant patients is described herein. The method comprises the steps of a) identifying an islet cell transplant patient, b) treating the patient with 2AMD or...
US20130090486 Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol  
A method of purifying 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol to obtain 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol in crystalline form using precipitation with hexane...
US20120244627 Methods for Quantifying Vitamin D Metabolites by Mass Spectrometry  
Provided are methods of detecting the presence or amount of a dihydroxyvitamin D metabolite in a sample using mass spectrometry. The methods generally comprise associating an amine with a...
US20110073810 PROCESS FOR PREPARING ISOTOPICALLY LABELED VITAMINS SUITABLE FOR USE AS ANALYTICAL REFERENCE STANDARDS  
The present invention is directed to a method for the synthesis of deuterium labeled Vitamin D and related compounds with a high level of deuterium incorporation, which are particularly suitable...
US20090311316 TREATING VITAMIN D INSUFFICIENCY AND DEFICIENCY WITH 25-HYDROXYVITAMIN D2 AND 25-HYDROXYVITAMIN D3  
Methods and compositions for treating 25-hydroxyvitamin D insufficiency and deficiency in a patient are described herein. The method includes orally administering to the patient a delayed,...
US20130252927 TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3  
The present invention relates to treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol). Optionally, vitamin D3 may be used...
US20120270839 COMPOSITIONS AND METHODS FOR CANCER TREATMENT  
Bromoacetoxycalcidiol (B3CD), which is structurally related to calcidiol, exhibits cytotoxic and apoptotic activity toward cancer cells, including highly aggressive neuroblastoma cells. A series...
US20070027333 Stereoselective synthesis of vitamin d analogues  
The present invention relates to intermediates useful for the synthesis of calcipotriol or calcipotriol monohydrate, to methods of producing said intermediates, and to methods of stereoselectively...
US20110213168 DEUTERATED VITAMIN D COMPOUNDS  
The invention relates to deuterated vitamin D compounds and the process for preparing and synthesizing a class of vitamin D compounds which can be isotopically substituted. These compounds can be...
US20100209536 Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases  
This invention provides methods of treating and preventing diseases or conditions of the immune system or infectious disease, involving administration of vitamin D and/or one or more antioxidants...
US20060166949 Vitamin d analogues, compositions comprising said analogues and their use  
Compounds according to formula I in which formula R1 and R2, which may be the same or different, represent halogen, (C1-C6)hydrocarbyl, optionally substituted with one or two hydroxyl group or one...
US20110137058 PREPARATION OF PARICALCITOL  
This invention relates to a method for purifying Paricalcitol by reverse phase chromatography. This invention also relates to a purified Paricalcitol prepared by said method. This invention...
US20130053587 Crystallization of 1alpha-Hydroxy-20-Methyl-2-Methylene-19,24,25,26,27-Pentanorvitamin D3  
A method of purifying 1α-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvita min D3 to obtain 1α-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvita min D3 in crystalline form. The...
US20110207952 CHOLESTEROL EXTRACTION FROM ALGAE AND PREPARATION OF VEGAN VITAMIN D3  
A process for producing vegan vitamin D3 from an algal waste processing stream by saponifying the waste stream to separate out and removing unsaponifiable cholesterol and converting it to vitamin...
US20130324750 Crystallization of (20R)-2-Methylene-19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3  
Disclosed are methods of purifying the compound (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3 to obtain the compound in crystalline form. The methods typically include the steps...
US20080280859 GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF  
The invention provides Gemini vitamin D3 compounds, methods for using the compounds to treat vitamin D3 associated states and pharmaceutical compositions containing the compounds.
US20130137662 USE OF CANTHAXANTHIN AND/OR 25-OH D3 FOR IMPROVED REPRODUCTIVITY AND PERFORMANCE OF ROOSTERS  
The present invention relates to the use canthaxanthin and/or 25-hydroxy vitamin D3 (25-OH D3) for improving reproductive performance of roosters. More particularly, the invention relates to the...
US20120108554 PROCESS FOR PREPARING HIGH PURITY 1alpha-HYDROXY VITAMIN D2  
The present invention relates to a process for purifying Doxercalciferol, a synthetic vitamin D analog, also known as 1α-hydroxy vitamin D2, to the purity greater than 99.5% by crystallization...
US20060052350 Crystalline forms of 1,24(S)-dihydroxy vitamin D2  
Provided are novel crystalline forms of 1,24-(S)-dihydroxy vitamin D2, including hydrates and solvates, and methods for making them. Also provided are pharmaceutical and nutraceutical compositions...
US20120184514 VITAMIN D COMPOUNDS AND METHODS FOR PREPARING SAME  
An air-stable, high-melt 1a-hydroxy-vitamin D3 compound, methods for preparing an animal feed composition, methods of preparing 1α-hydroxy-vitamin D3, methods of enhancing phytate phosphorus and...
US20070244072 1a-Hydroxy-2-(3'-Hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof  
Disclosed are 1α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds, pharmaceutical compositions, and methods of making and treatment thereof. The compounds are generally directed to...
US20090075953 DEUTERIUM-ENRICHED ED-71  
The present application describes deuterium-enriched ED-71, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
US20110039811 TREATING HYPERGLYCEMIA WITH 25-HYDROXYVITAMIN D3  
We disclose treating hyperglycemia in a human with 25-hydroxyvitamin D3 (calcifediol). Blood glucose is reduced to a level which is closer to normal than baseline. Vitamin D3 (cholecalciferol) may...
US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs  
This invention discloses 2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs, and specifically 2-methylene-(20S,25S)-19,26-dinor-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This...
US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs  
This invention discloses 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs, and specifically 2-methylene-(20S,25R)-19,26-dinor-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This...
US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs  
This invention discloses (20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalcife rol-vitamin D analogs, and specifically (20R)-23,23-difluoro-1...
US20090170818 (20S)-23,23-Difluoro-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs  
This invention discloses (20S)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalcife rol-vitamin D analogs, and specifically...
US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs  
This invention discloses 2-methylene-(20R,25S)-19,27-dinor-(22E)-vitamin D analogs, and specifically 2-methylene-(20R,25S)-19,27-dinor-(22E)-1α,25-dihydroxyvitam in D3, and pharmaceutical uses...
US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs  
This invention discloses 2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs, and specifically 2-methylene-(20S,25S)-19,27-dinor-(22E)-1α,25-dihydroxyvitam in D3, and pharmaceutical uses...
US20100069339 NOVEL METHOD OF TREATMENT OF MALE SUB-FERTILITY  
There is provided a method of treatment of male sub-fertility by using a vitamin D compound. Compositions and uses are also provided.
US20050182033 Vitamin D receptor antagonists and their use in treating asthma  
Various compounds such as those having the formula I and XIV where the variables have the values described herein antagonize the vitamin D receptor and are useful in treating conditions such as...
US20100087405 FOOD SUPPLEMENTATION COMPOSITION CONTAINING ONE OR MORE VITAMIN D3 COMPOUNDS AND ONE OR MORE MAGNESIUM SALTS  
Use of one or more vitamin D3 compounds chosen from the group 1-α-hydroxy vitamin D3, 25-hydroxy vitamin D3, 1-α-,25-dihydroxy vitamin D3, in combination with one or more magnesium salts to...
US20070088007 Method for preparing analogue of vitamin D  
A method for preparing analogues of C1,C24-dihydroxy-vitamin D is disclosed. Especially the method for preparing calcipotriol and tacalcitol from a starting material of Vitamin D2 is disclosed...
US20090131379 VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING  
The invention relates to compounds that are vitamin D receptor activators, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such...
US20140051875 CRYSTALLINE FORM OF MAXACALCITOL  
The present invention relates to maxacalcitol hydrate, a new crystalline form of maxacalcitol, with superior technical properties e.g. in the manufacture of crystal suspension formulations, and...
US20090281340 1ALPHA-HYDROXY-2-(3'-HYDROXYPROPYLIDENE)-19-NOR-VITAMIN D COMPOUNDS AND METHODS OF MAKING AND TREATMENT THEREOF  
Disclosed are 1α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds, pharmaceutical compositions, and methods of making and treatment thereof. The compounds are generally directed to...
US20090298800 1,25-DIHYDROXY, 20-CYCLOPROPYL,26-27-DEUTEROALKYL VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF  
The invention provides vitamin D3 analogs of cholecalciferol, substituted at carbons-26 and 27 with deuterated alkyl groups, e.g., trideuteromethyl, wherein carbon-16 is a single or double bond,...
US20110274743 Medicament for the Treatment of Pain and Inflammation  
The use of vitamin D3 for the manufacture of a medicament for the transdermal treatment of neurogenic inflammation and neuropathic pain (including peripheral neuropathic pain); also a method for...
US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs  
This invention discloses 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs, and specifically 2-methylene-20-methyl-1α-hydroxy-19,24,25,26,27-pentanor-vit amin D3, and pharmaceutical...

Matches 1 - 50 out of 160 1 2 3 4 >